Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ambuj Kumar
Benjamin Djulbegovic

Showing results (1-10 of 634) with videos related to

Pageof 64
Sort By:
Lancet (London, England)|May 20, 2008
Multiple myeloma: detecting the effects of new treatmentsBenjamin Djulbegovic, Ambuj Kumar
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators|December 28, 2002
Why evidence based oncology managementAmbuj Kumar, Benjamin Djulbegovic
Clinical Evidence|September 16, 2006
Myeloma (multiple)Ambuj Kumar, Benjamin Djulbegovic
Acta Haematologica|December 15, 2010
Treatment of patients with multiple myeloma: an overview of systematic reviewsAmbuj Kumar, Sanja Galeb, Benjamin Djulbegovic
Cancer Treatment Reviews|November 4, 2006
Evidence profiles for breast cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Cancer Treatment Reviews|September 30, 2006
Evidence profiles for lung cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Cancer Treatment Reviews|August 18, 2006
What kind of evidence do patients and practitioners need: evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harmsBenjamin Djulbegovic, Heloisa P Soares, Ambuj Kumar
Cancer Treatment Reviews|August 22, 2006
Evidence profiles for colo-rectal cancer: benefit/harms data based on the totality of randomized evidenceAmbuj Kumar, Heloisa P Soares, Benjamin Djulbegovic
Plos One|August 15, 2014
Evolution of treatment regimens in multiple myeloma: a social network analysisHelen Mahony, Athanasios Tsalatsanis, Ambuj Kumar, et al.
The Cochrane Database of Systematic Reviews|December 19, 2017
Bisphosphonates in multiple myeloma: an updated network meta-analysisRahul Mhaskar, Ambuj Kumar, Branko Miladinovic, et al.
Pageof 64

Showing results (1-10 of 634) with videos related to

Sort By:
Pageof 64
Lancet (London, England)|May 20, 2008
Multiple myeloma: detecting the effects of new treatmentsBenjamin Djulbegovic, Ambuj Kumar
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators|December 28, 2002
Why evidence based oncology managementAmbuj Kumar, Benjamin Djulbegovic
Clinical Evidence|September 16, 2006
Myeloma (multiple)Ambuj Kumar, Benjamin Djulbegovic
Acta Haematologica|December 15, 2010
Treatment of patients with multiple myeloma: an overview of systematic reviewsAmbuj Kumar, Sanja Galeb, Benjamin Djulbegovic
Cancer Treatment Reviews|November 4, 2006
Evidence profiles for breast cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Cancer Treatment Reviews|September 30, 2006
Evidence profiles for lung cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Cancer Treatment Reviews|August 18, 2006
What kind of evidence do patients and practitioners need: evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harmsBenjamin Djulbegovic, Heloisa P Soares, Ambuj Kumar
Cancer Treatment Reviews|August 22, 2006
Evidence profiles for colo-rectal cancer: benefit/harms data based on the totality of randomized evidenceAmbuj Kumar, Heloisa P Soares, Benjamin Djulbegovic
Plos One|August 15, 2014
Evolution of treatment regimens in multiple myeloma: a social network analysisHelen Mahony, Athanasios Tsalatsanis, Ambuj Kumar, et al.
The Cochrane Database of Systematic Reviews|December 19, 2017
Bisphosphonates in multiple myeloma: an updated network meta-analysisRahul Mhaskar, Ambuj Kumar, Branko Miladinovic, et al.
Pageof 64